Clinigen Acquires SSI Strategy
November 21, 2025
Clinigen has completed the acquisition of SSI Strategy, adding SSI's strategic advisory capabilities and an established U.S. and European footprint to Clinigen's global pharmaceutical services platform. The deal brings over 200 employees (including ~145 consultants) and a deep biotech client base to Clinigen, expanding its end-to-end lifecycle services from clinical strategy through global commercialisation.
- Buyers
- Clinigen
- Targets
- SSI Strategy
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
SSI Strategy Acquires Fiore Healthcare Advisors
June 29, 2021
Healthcare Services
SSI Strategy, a life sciences consultancy backed by Amulet Capital Partners, has acquired Fiore Healthcare Advisors, a Boston-based pharmacovigilance and clinical research consultancy. The acquisition adds Safety Physicians and clinical research experts to SSI, expanding the company's drug safety, pharmacovigilance and clinical research capabilities for early- and mid-stage biopharma clients.
-
SSI Strategy Acquires NDA Group AB
August 15, 2023
Healthcare Services
SSI Strategy has entered into a definitive agreement to acquire NDA Group AB, a regulatory affairs and drug development consultancy, to create an integrated life sciences consultancy offering end-to-end drug development and regulatory services. The combination, supported by SSI's private equity partner Amulet Capital Partners, expands SSI's regulatory capabilities and geographic footprint across the U.S. and Europe.
-
Amulet Capital Partners Makes Growth Investment in SSI Strategy
December 21, 2020
Healthcare Services
Amulet Capital Partners (a healthcare-focused private equity firm) made a growth equity investment in SSI Strategy Holdings LLC, a Parsippany, New Jersey-based life sciences consulting firm, to accelerate the company’s growth and expand strategic services including a new Gene Therapy Accelerator. The capital will fund team expansion, adjacent service lines and potential tuck-in acquisitions; Simon Kennedy joined SSI Strategy's board in conjunction with the investment.
-
Triton (via Triley Bidco) Acquires Clinigen
January 17, 2022
Pharmaceuticals
Triton, through a newly-formed acquisition vehicle Triley Bidco Limited, completed an all-cash recommended offer to acquire Clinigen for 925 pence per share. Triton said it will support Clinigen’s next growth phase by extending geographic reach, pursuing inorganic growth opportunities and strengthening Clinigen’s services and digital platform.
-
NextGen Healthcare Acquires TSI Healthcare
November 30, 2022
Healthcare Services
NextGen Healthcare, Inc. agreed to acquire TSI Healthcare, a Chapel Hill, North Carolina-based value-added reseller of NextGen practice management and EHR solutions. The deal includes $68 million in cash upfront plus up to $22 million in earnout, is effective November 30, 2022, and is expected to add approximately $10–12 million of revenue in the remaining four months of fiscal 2023 while expanding NextGen’s presence in specialty physician markets.
-
SSI Diagnostica Group Acquires Gulf Coast Scientific
April 28, 2025
Medical Devices
SSI Diagnostica Group (Denmark) has acquired Gulf Coast Scientific, a Florida-based in‑vitro diagnostics company specializing in Urea Breath Testing for Helicobacter pylori. The deal expands SSI Diagnostica Group's gastrointestinal diagnostic portfolio and strengthens its footprint in the US clinical diagnostics market.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.